Search results
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 2 days agoThe Centers for Disease Control and Prevention recommends everyone 6 months and older get an updated...
Gateway - The Root
The Root· 6 days agoLast week, the White House warned that if there was no additional money passed by Congress to replenish COVID measures, things like surveillance for new variants and purchases of preventive ...
US FDA approves Merck's pneumococcal vaccine for adults By Reuters
Investing.com· 6 days agoMerck's vaccine, branded Capvaxive, helped produce an immune response against all 21 serotypes, or...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 3 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
CNBC· 6 days agoThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and ...
Gateway - Quartz
Quartz· 5 days agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines off ...
Gateway - Quartz
Quartz· 4 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...
US FDA Approves Merck's Pneumococcal Vaccine for Adults
US News & World Report· 6 days agoMerck's vaccine, branded Capvaxive, helped produce an immune response against all 21 serotypes, or variations of the bacteria, that the shot targeted in a variety of adult ...
Gateway - Jalopnik
Jalopnik· 5 days agoIn an article posted on CNBC on Monday, the White House had shared more than 90 percent of federal workers had received at least one COVID-19 vaccine dose
Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer
Clinical Trials Arena via Yahoo Finance· 3 days ago(SWOG) is investigating different strains of BCG in a Phase III trial (NCT03091660). The trial is...
